Gonococcal susceptibility to antimicrobials in Baltimore, 1988-1994: What was the impact of ciprofloxacin as first-line therapy for gonorrhea?

Research output: Contribution to journalArticle

Abstract

Background: Single-dose, oral quinolones have been a recommended treatment option for gonorrhea since 1989 and have since been used as first-line therapy for gonorrhea in Baltimore. Methods: The impact of this strategy on antimicrobial susceptibility patterns in Neisseria gonorrhoeae was assessed utilizing data collected as part of the National Gonococcal Isolate Surveillance system. This system evaluates a systematically collected sample. Minimum inhibitory concentrations to penicillin, tetracycline, ceftriaxone, and ciprofloxacin were determined by agar dilution. Results: Between January 1988 and September 1994, 1,846 gonococcal isolates were evaluated. The proportion of isolates with plasmid-mediated resistance (penicillinase- producing Neisseria gonorrhoeae or tetracycline-resistant Neisseria gonorrhoeae) increased from 22% in 1988 to 46% in 1992 and then dropped to 20% in 1994. In contrast, the prevalence of chromosomally mediated resistant isolates ranged between 3% and 10%. Between 1988 and 1994, the geometric mean penicillin and tetracycline minimum inhibitory concentrations decreased slightly (penicillin: from 0.509 μg/ml to 0.369 μg/ml; tetracycline: from 1.01 μg/ml to 0.767 μg/ml). The mean ceftriaxone MIC increased from 0.005 μg/ml in 1988 to 0.021 μg/ml in 1992, and then abruptly decreased. Ciprofloxacin minimum inhibitory concentrations did not change substantially during the study period. Concurrent studies performed in this community suggest that quinolones were infrequently used for infections other than sexually transmitted ones during this time period. Conclusions: Single-dose quinolone therapy does not appear to foster development of resistant gonococcal isolates. However, resistance may develop as a result of complex ecological interactions with the community, underscoring the need for continued surveillance.

Original languageEnglish (US)
Pages (from-to)213-218
Number of pages6
JournalSexually Transmitted Diseases
Volume23
Issue number3
StatePublished - May 1996

Fingerprint

Baltimore
Gonorrhea
Ciprofloxacin
Tetracycline
Neisseria gonorrhoeae
Quinolones
Microbial Sensitivity Tests
Penicillins
Ceftriaxone
Penicillinase
Therapeutics
Sexually Transmitted Diseases
Agar
Plasmids
Cohort Studies

ASJC Scopus subject areas

  • Dermatology
  • Public Health, Environmental and Occupational Health
  • Microbiology (medical)

Cite this

@article{973005e687424b5cba72c7522c1b8bef,
title = "Gonococcal susceptibility to antimicrobials in Baltimore, 1988-1994: What was the impact of ciprofloxacin as first-line therapy for gonorrhea?",
abstract = "Background: Single-dose, oral quinolones have been a recommended treatment option for gonorrhea since 1989 and have since been used as first-line therapy for gonorrhea in Baltimore. Methods: The impact of this strategy on antimicrobial susceptibility patterns in Neisseria gonorrhoeae was assessed utilizing data collected as part of the National Gonococcal Isolate Surveillance system. This system evaluates a systematically collected sample. Minimum inhibitory concentrations to penicillin, tetracycline, ceftriaxone, and ciprofloxacin were determined by agar dilution. Results: Between January 1988 and September 1994, 1,846 gonococcal isolates were evaluated. The proportion of isolates with plasmid-mediated resistance (penicillinase- producing Neisseria gonorrhoeae or tetracycline-resistant Neisseria gonorrhoeae) increased from 22{\%} in 1988 to 46{\%} in 1992 and then dropped to 20{\%} in 1994. In contrast, the prevalence of chromosomally mediated resistant isolates ranged between 3{\%} and 10{\%}. Between 1988 and 1994, the geometric mean penicillin and tetracycline minimum inhibitory concentrations decreased slightly (penicillin: from 0.509 μg/ml to 0.369 μg/ml; tetracycline: from 1.01 μg/ml to 0.767 μg/ml). The mean ceftriaxone MIC increased from 0.005 μg/ml in 1988 to 0.021 μg/ml in 1992, and then abruptly decreased. Ciprofloxacin minimum inhibitory concentrations did not change substantially during the study period. Concurrent studies performed in this community suggest that quinolones were infrequently used for infections other than sexually transmitted ones during this time period. Conclusions: Single-dose quinolone therapy does not appear to foster development of resistant gonococcal isolates. However, resistance may develop as a result of complex ecological interactions with the community, underscoring the need for continued surveillance.",
author = "Zenilman, {Jonathan Mark}",
year = "1996",
month = "5",
language = "English (US)",
volume = "23",
pages = "213--218",
journal = "Sexually Transmitted Diseases",
issn = "0148-5717",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Gonococcal susceptibility to antimicrobials in Baltimore, 1988-1994

T2 - What was the impact of ciprofloxacin as first-line therapy for gonorrhea?

AU - Zenilman, Jonathan Mark

PY - 1996/5

Y1 - 1996/5

N2 - Background: Single-dose, oral quinolones have been a recommended treatment option for gonorrhea since 1989 and have since been used as first-line therapy for gonorrhea in Baltimore. Methods: The impact of this strategy on antimicrobial susceptibility patterns in Neisseria gonorrhoeae was assessed utilizing data collected as part of the National Gonococcal Isolate Surveillance system. This system evaluates a systematically collected sample. Minimum inhibitory concentrations to penicillin, tetracycline, ceftriaxone, and ciprofloxacin were determined by agar dilution. Results: Between January 1988 and September 1994, 1,846 gonococcal isolates were evaluated. The proportion of isolates with plasmid-mediated resistance (penicillinase- producing Neisseria gonorrhoeae or tetracycline-resistant Neisseria gonorrhoeae) increased from 22% in 1988 to 46% in 1992 and then dropped to 20% in 1994. In contrast, the prevalence of chromosomally mediated resistant isolates ranged between 3% and 10%. Between 1988 and 1994, the geometric mean penicillin and tetracycline minimum inhibitory concentrations decreased slightly (penicillin: from 0.509 μg/ml to 0.369 μg/ml; tetracycline: from 1.01 μg/ml to 0.767 μg/ml). The mean ceftriaxone MIC increased from 0.005 μg/ml in 1988 to 0.021 μg/ml in 1992, and then abruptly decreased. Ciprofloxacin minimum inhibitory concentrations did not change substantially during the study period. Concurrent studies performed in this community suggest that quinolones were infrequently used for infections other than sexually transmitted ones during this time period. Conclusions: Single-dose quinolone therapy does not appear to foster development of resistant gonococcal isolates. However, resistance may develop as a result of complex ecological interactions with the community, underscoring the need for continued surveillance.

AB - Background: Single-dose, oral quinolones have been a recommended treatment option for gonorrhea since 1989 and have since been used as first-line therapy for gonorrhea in Baltimore. Methods: The impact of this strategy on antimicrobial susceptibility patterns in Neisseria gonorrhoeae was assessed utilizing data collected as part of the National Gonococcal Isolate Surveillance system. This system evaluates a systematically collected sample. Minimum inhibitory concentrations to penicillin, tetracycline, ceftriaxone, and ciprofloxacin were determined by agar dilution. Results: Between January 1988 and September 1994, 1,846 gonococcal isolates were evaluated. The proportion of isolates with plasmid-mediated resistance (penicillinase- producing Neisseria gonorrhoeae or tetracycline-resistant Neisseria gonorrhoeae) increased from 22% in 1988 to 46% in 1992 and then dropped to 20% in 1994. In contrast, the prevalence of chromosomally mediated resistant isolates ranged between 3% and 10%. Between 1988 and 1994, the geometric mean penicillin and tetracycline minimum inhibitory concentrations decreased slightly (penicillin: from 0.509 μg/ml to 0.369 μg/ml; tetracycline: from 1.01 μg/ml to 0.767 μg/ml). The mean ceftriaxone MIC increased from 0.005 μg/ml in 1988 to 0.021 μg/ml in 1992, and then abruptly decreased. Ciprofloxacin minimum inhibitory concentrations did not change substantially during the study period. Concurrent studies performed in this community suggest that quinolones were infrequently used for infections other than sexually transmitted ones during this time period. Conclusions: Single-dose quinolone therapy does not appear to foster development of resistant gonococcal isolates. However, resistance may develop as a result of complex ecological interactions with the community, underscoring the need for continued surveillance.

UR - http://www.scopus.com/inward/record.url?scp=0029934633&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029934633&partnerID=8YFLogxK

M3 - Article

C2 - 8724511

AN - SCOPUS:0029934633

VL - 23

SP - 213

EP - 218

JO - Sexually Transmitted Diseases

JF - Sexually Transmitted Diseases

SN - 0148-5717

IS - 3

ER -